Literature DB >> 35001599

[The COVID-19 Epidemic: the experience in the Social and Health Care Center of the Mantua District (Lombardy Region, Northern Italy)].

Salvatore Casari1, Giuseppe Lucchini2, Enrico Burato3, Riccardo Bertoletti4, Renzo Boscaini4, Angela Bellani5, Luisa Lombardi6, Nicola Benedini3, Elisa Firriolo3, Franco Vallicella7, Giuseppe Ferrari4, Simona Aurelia Bellometti4, Consuelo Basili8, Raffaello Stradoni4.   

Abstract

OBJECTIVES: to describe the course of COVID-19 epidemic in the hospitals of the ASST of Mantua (Lombrady Region, Northern Italy) from February 2020 to April 2021.
DESIGN: observational study. SETTING AND PARTICIPANTS: data from hospital discharging chart of all patients admitted to the hospitals of ASST were collected from 26.02.2020 to 30.04.2021 with COVID-19 diagnosis. Data from Emergency Rooms for patients evaluated but not admitted to departments were also collected. MAIN OUTCOME MEASURES: the data from hospital discharging were crossed for diagnosis with data from laboratory. The department were classified into 'low intensity' and 'middle/high intensity'. The comparison was according to the different periods of epidemic.
RESULTS: patients admitted to the hospitals were 2,738: 510 died (17.3%) and 1,736 patients were evaluated in the Emergency Rooms but not admitted to departments. Among these patients, 166 died (9.6%). The prevailing age class were >=65 years, with a trend to reduction in the third wave. The proportion of admission in middle/high intensity departments was significantly higher in the second wave than in the first. N. 510 deaths by 2,738 (17.3%) were observed, with significant reduction in the second and third waves in the low intensity departments (from 21.9% to 14.3% and 12.7%) (p<0.001), while mortality was substantially unchanged in the middle/high intensity departments (28.0%, 29.6%, and 28.3%). The mortality for patients with >=65 years was 26.7%. Females showed lower mortality (OR 0.690; CI95% 0.560-0.840) and lower incidence of admissions in middle/high intensity departments (OR 0.556; CI95% 0.459-0.673) in the three waves. Finally, including also the patients not admitted, the general mortality was 15.1%.
CONCLUSIONS: a worse outcome by mortality and severity of disease was observed for male gender compared to female and for older age classes. Moreover, a significant improvement of outcomes in the second and third waves, compared to the first, was pointed out.

Entities:  

Keywords:  COVID-19; Mantua district; Mortality; Risk factors

Mesh:

Year:  2021        PMID: 35001599     DOI: 10.19191/EP21.6.142

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  2 in total

1.  Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.

Authors:  Massimo Franchini; Daniele Focosi; Elena Percivalle; Massimiliano Beccaria; Martina Garuti; Omar Arar; Antonietta Pecoriello; Fabio Spreafico; Graziana Greco; Stefano Bertacco; Marco Ghirardini; Tiziana Santini; Michele Schiavulli; Muzzica Stefania; Thaililja Gagliardo; Josè Camilla Sammartino; Alessandro Ferrari; Matteo Zani; Alessia Ballotari; Claudia Glingani; Fausto Baldanti
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

2.  Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience.

Authors:  Massimo Franchini; Claudia Glingani; Giuseppe De Donno; Giuseppe Lucchini; Massimiliano Beccaria; Massimo Amato; Gian Paolo Castelli; Leonardo Bianciardi; Mauro Pagani; Marco Ghirardini; Giuseppe Puma; Barbara Presciuttini; Maria Teresa Costantino; Marilena Frigato; Verena Crosato; Giorgio Tiecco; Alice Mulè; Dorothea Angela Papalia; Francesco Inglese; Fabio Spreafico; Martina Garuti; Antonietta Pecoriello; Giulia Cervi; Graziana Greco; Vanni Galavotti; Tiziana Santini; Angela Berselli; Carlo Montalto; Riccardo Bertoletti; Simona Aurelia Bellometti; Enrico Capuzzo; Dario Benazzi; Gianpaolo Grisolia; Fabio Pajola; Raffaello Stradoni; Matteo Zani; Adriano Verzola; Vito Codeluppi; Silvia Vesentini; Elisa Bellocchio; Marco Candini; Giorgina Ambrosi; Francesca Carandina; Cleante Scarduelli; Albino Reggiani; Salvatore Casari
Journal:  Life (Basel)       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.